Supportive Test for Acid-Related Symptoms (STARS I) with esomeprazole and a following 7-week, double-blind, randomized, placebo controlled treatment period in subjects with upper gastrointestinal symptoms and with normal findings at esophagogastroduodenoscopy.
18 Years - 70 Years
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals
No locations available